Study protocol of LANTana: a phase Ib study to investigate epigenetic modification of somatostatin receptor-2 with ASTX727 to improve therapeutic outcome with [177Lu]Lu-DOTA-TATE in patients with metastatic neuroendocrine tumours, UK.
Ravindhi MurphyGurvin ChanderMaria MartinezCaroline WardSairah R KhanMitesh NaikTara BarwickEric AboagyeRohini SharmaPublished in: BMJ open (2023)
EUDRACT number: 2020-003800-15, NCT05178693.